Advanced search
Publication Cover
Scandinavian Journal of Gastroenterology Volume 46, 2011 - Issue 4
Submit an article Journal homepage
370
Views
29
CrossRef citations to date
0
Altmetric
Inflammatory bowel disease

Blood chemistry markers for evaluation of inflammatory activity in Crohn's disease during infliximab therapy

Maria H. Lönnkvist Department of Medicine, Gastroenterology and Hepatology Unit, Karolinska University Hospital Solna, Sweden
,
Elvar Theodorsson Department of Clinical and Experimental Medicine/Clinical Chemistry, Linköping University, Linköping, Sweden
,
Mikael Holst Department of Woman and Child Health, Karolinska University Hospital Solna, Sweden
,
Tryggve Ljung Merck, Sharp & Dohme, Stockholm, Sweden
&
Per M. Hellström Department of Medical Sciences, Uppsala University Hospital, Uppsala, SwedenCorrespondence[email protected]
Pages 420-427 | Received 01 Sep 2010, Accepted 07 Nov 2010, Published online: 30 Nov 2010

Citations (29)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (5)

Johanna Engström, Maria Lönnkvist, Ragnar Befrits, Tryggve Ljung, Hetzel Diaz-Tartera, Mikael Holst & Per M. Hellström. (2019) Comparison of fecal calprotectin and serum C-reactive protein in early prediction of outcome to infliximab induction therapy. Scandinavian Journal of Gastroenterology 54:9, pages 1081-1088.
Read now
S. Desmedt, V. Desmedt, J. R. Delanghe, R. Speeckaert & M. M. Speeckaert. (2017) The intriguing role of soluble urokinase receptor in inflammatory diseases. Critical Reviews in Clinical Laboratory Sciences 54:2, pages 117-133.
Read now
Rocio Ferreiro-Iglesias, Manuel Barreiro-de Acosta, Aurelio Lorenzo-Gonzalez & Juan Enrique Dominguez-Muñoz. (2016) Usefulness of a rapid faecal calprotectin test to predict relapse in Crohn’s disease patients on maintenance treatment with adalimumab. Scandinavian Journal of Gastroenterology 51:4, pages 442-447.
Read now
Kaija-Leena Kolho, Elsa Valtonen, Hanne Rintamäki & Erkki Savilahti. (2012) Soluble urokinase plasminogen activator receptor suPAR as a marker for inflammation in pediatric inflammatory bowel disease. Scandinavian Journal of Gastroenterology 47:8-9, pages 951-955.
Read now
Kristian Bjøro. (2011) This Month in Scandinavian Journal of Gastroenterology. Scandinavian Journal of Gastroenterology 46:4, pages 387-388.
Read now

Articles from other publishers (24)

Amirmohammad Khalaji, Nastaran Babajani, Zahra Amirsardari, Behrad Saeedian, Soheil Peiman, Nathan A Berger & Amir Hossein Behnoush. (2023) Unveiling the Ghrelin and Obestatin Roles in Inflammatory Bowel Diseases: A Systematic Review and Meta-Analysis Assessing Their Pathogenic Implications and Biomarker Utility. Inflammatory Bowel Diseases.
Crossref
Huriye Erbak Yılmaz, Saliha Aksun, Süleyman Günay, Ferhan Elmalı & Cem Çekiç. (2023) Evaluation of plasma soluble urokinase plasminogen activator receptor (SuPAR) levels in ulcerative colitis. Arab Journal of Gastroenterology.
Crossref
Iraklis Tsangaris, Nikolaos Antonakos, Massimo Fantoni, Gilles Kaplanski, Evdoxia Kyriazopoulou, Francisco Veas & Mark Clemens. (2023) BIOMARKERS: CAN THEY REALLY GUIDE OUR DAILY PRACTICE?. Shock 59:3S, pages 16-20.
Crossref
Burcin Özdirik, Martin Maibier, Maria Scherf, Jule Marie Nicklaus, Josephine Frohme, Tobias Puengel, Dirk Meyer zum Büschenfelde, Frank Tacke, Tobias Mueller & Michael Sigal. (2022) Soluble Urokinase Plasminogen Activator Receptor Levels Are Associated with Severity of Fibrosis in Patients with Primary Sclerosing Cholangitis. Journal of Clinical Medicine 11:9, pages 2479.
Crossref
Evgeny Knyazev, Diana Maltseva, Maria Raygorodskaya & Maxim Shkurnikov. (2021) HIF-Dependent NFATC1 Activation Upregulates ITGA5 and PLAUR in Intestinal Epithelium in Inflammatory Bowel Disease. Frontiers in Genetics 12.
Crossref
Dario Sorrentino, Vu Q. Nguyen & Maithili V. Chitnavis. (2019) Capturing the Biologic Onset of Inflammatory Bowel Diseases: Impact on Translational and Clinical Science. Cells 8:6, pages 548.
Crossref
Lamiaa Hamie, Georges Daoud, Georges Nemer, Tarek Nammour, Alissar El Chediak, Imad W Uthman, Abdul Ghani Kibbi, Assaad Eid & Mazen Kurban. (2018) SuPAR, an emerging biomarker in kidney and inflammatory diseases. Postgraduate Medical Journal 94:1115, pages 517-524.
Crossref
Rocio Ferreiro-Iglesias, Manuel Barreiro-de Acosta, Aurelio Lorenzo-Gonzalez & Juan E. Dominguez-Muñoz. (2018) Accuracy of Consecutive Fecal Calprotectin Measurements to Predict Relapse in Inflammatory Bowel Disease Patients Under Maintenance With Anti-TNF Therapy. Journal of Clinical Gastroenterology 52:3, pages 229-234.
Crossref
Víctor Manuel Navas-López, Gemma Pujol Muncunill, Enrique Llerena, María Navalón Rubio, David Gil-Ortega, Vicente Varea-Calderón, Carlos Sierra Salinas & Javier Martin-de-Carpi. (2018) Efectividad y seguridad en nuestro entorno de adalimumab como tratamiento anti-TNF de primera linea en niños con enfermedad de Crohn. Anales de Pediatría 88:2, pages 89-99.
Crossref
Víctor Manuel Navas-López, Gemma Pujol-Muncunill, Enrique Llerena, María Navalón Rubio, David Gil-Ortega, Vicente Varea-Calderón, Carlos Sierra Salinas & Javier Martin-de-Carpi. (2018) A real-world study focused on the effectiveness and safety of adalimumab as first-line anti-TNF treatment for paediatric Crohn's disease. Anales de Pediatría (English Edition) 88:2, pages 89-99.
Crossref
Pablo Miranda-García, María Chaparro & Javier P. Gisbert. (2016) Correlation between serological biomarkers and endoscopic activity in patients with inflammatory bowel disease. Gastroenterología y Hepatología 39:8, pages 508-515.
Crossref
Pablo Miranda-García, María Chaparro & Javier P. Gisbert. (2016) Correlation between serological biomarkers and endoscopic activity in patients with inflammatory bowel disease. Gastroenterología y Hepatología (English Edition) 39:8, pages 508-515.
Crossref
Sarah Bamberger, Christine Martinez Vinson, Damir Mohamed, Jérôme Viala, Jean-Claude Carel, Jean-Pierre Hugot & Dominique Simon. (2016) Growth and Adult Height in Patients with Crohn's Disease Treated with Anti-Tumor Necrosis Factor α Antibodies. PLOS ONE 11:9, pages e0163126.
Crossref
Dario Sorrentino. (2016) Preclinical and Undiagnosed Crohnʼs Disease. Inflammatory Bowel Diseases 22:2, pages 476-486.
Crossref
Rocio Ferreiro-Iglesias, Manuel Barreiro-de Acosta, Manuel Otero Santiago, Aurelio Lorenzo Gonzalez, Carmen Alonso de la Peña, Alfonso J. Benitez Estevez & Juan Enrique Dominguez-Muñoz. (2016) Fecal Calprotectin as Predictor of Relapse in Patients With Inflammatory Bowel Disease Under Maintenance Infliximab Therapy. Journal of Clinical Gastroenterology 50:2, pages 147-151.
Crossref
Marco Genua, Silvia D'Alessio, Javier Cibella, Alessandro Gandelli, Emanuela Sala, Carmen Correale, Antonino Spinelli, Vincenzo Arena, Alberto Malesci, Sergio Rutella, Victoria A Ploplis, Stefania Vetrano & Silvio Danese. (2015) The urokinase plasminogen activator receptor (uPAR) controls macrophage phagocytosis in intestinal inflammation. Gut 64:4, pages 589-600.
Crossref
Björn Meijers, Ruben Poesen, Kathleen Claes, Ruth Dietrich, Bert Bammens, Ben Sprangers, Maarten Naesens, Markus Storr, Dirk Kuypers & Pieter Evenepoel. (2015) Soluble urokinase receptor is a biomarker of cardiovascular disease in chronic kidney disease. Kidney International 87:1, pages 210-216.
Crossref
M. Prager & C. Büning. (2014) Klinik, CRP, Calprotectin, MRT oder Endoskopie?Clinical symptoms, C-reactive protein, calprotectin, MRI or endoscopy?. coloproctology 36:4, pages 250-258.
Crossref
Jesica C. Makanyanga, Doug Pendsé, Nikolaos Dikaios, Stuart Bloom, Sara McCartney, Emma Helbren, Elaine Atkins, Terry Cuthbertson, Shonit Punwani, Alastair Forbes, Steve Halligan & Stuart A. Taylor. (2013) Evaluation of Crohn’s disease activity: Initial validation of a magnetic resonance enterography global score (MEGS) against faecal calprotectin. European Radiology 24:2, pages 277-287.
Crossref
Margret E. Bock, Heather E. Price, Lorenzo Gallon & Craig B. Langman. (2013) Serum Soluble Urokinase-Type Plasminogen Activator Receptor Levels and Idiopathic FSGS in Children. Clinical Journal of the American Society of Nephrology 8:8, pages 1304-1311.
Crossref
Amit Assa, Corina Hartman, Batia Weiss, Efrat Broide, Yoram Rosenbach, Noam Zevit, Yoram Bujanover & Raanan Shamir. (2013) Long-term outcome of tumor necrosis factor alpha antagonist's treatment in pediatric Crohn's disease. Journal of Crohn's and Colitis 7:5, pages 369-376.
Crossref
M. Prager & C. Büning. (2013) Klinik, CRP, Calprotectin, MRT oder Endoskopie?Clinical symptoms, C-reactive protein, calprotectin, MRI or endoscopy?. Der Gastroenterologe 8:3, pages 187-196.
Crossref
Yara Backes, Koenraad F. van der Sluijs, David P. Mackie, Frank Tacke, Alexander Koch, Jyrki J. Tenhunen & Marcus J. Schultz. (2012) Usefulness of suPAR as a biological marker in patients with systemic inflammation or infection: a systematic review. Intensive Care Medicine 38:9, pages 1418-1428.
Crossref
Wolfram Koppensteiner, Vinzenz Auersperg & Gabriele Halwachs-Baumann. (2011) The use of inflammatory markers as a method for discharging patients post hip or knee arthroplasty. Clinical Chemistry and Laboratory Medicine 49:10.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.